Response Pharmaceuticals
Manufacturing · Virginia, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1104 W Broad St, Falls Church, Virginia,...Revenue
$7.3 MillionIndustry
ZI Rank: 1
About Response Pharmaceuticals
Response Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Response Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Response Pharmaceuticals is spiking on competitors!
Funding: Get notified immidiatlly once Response Pharmaceuticals has new funding data
Website visits: Recent activity has been detected on your website
Click to see if Response Pharmaceuticals had a recent Job posting/layoffs
Earning: See what the market has to say on Response Pharmaceuticals recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Response Pharmaceuticals
Product Launch: Get notified when Response Pharmaceuticals launches new products
Check if Response Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Response Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Response Pharmaceuticals Tech Stack
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Response Pharmaceuticals
Response Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for weight management and metabolic health, particularly targeting high-need patient populations. The company is focused on its drug candidate RDX-002, which is being evaluated in various clinical trials for patients discontinuing GL... Read More
